Echokardiografické zhodnocení aortální chlopnĕ u nestabilního pacienta - základní vyšetření.

Autor: Šachl, R.¹, Dobiáš, M.¹, Kunstýř, J.¹ jan.kunstyr@vfn.cz

Publikováno v: Anaesthesiology & Intensive Medicine / Anesteziologie a Intenzivní Medicína. 2015, Vol. 26 Issue 6, p350-354. 5p.

The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox

Autor: Balik, M., Svobodova, E., Porizka, M., Maly, M., Brestovansky, P., Volny, L., Brozek, T., Bartosova, T., Jurisinova, I., Mevaldova, Z., Misovic, O., Novotny, A., Horejsek, J., Otahal, M., Flaksa, M., Stach, Z., Rulisek, J., Trachta, P., Kolman, J., Sachl, R., Kunstyr, J., Kopecky, P., Romaniv, S., Huptych, M., Svarc, M., Hodkova, G., Fichtl, J., Mlejnsky, F., Grus, T., Belohlavek, J., Lips, M., Blaha, J.

Publikováno v: In Journal of Critical Care December 2022 72

Internal jugular vein collapsibility does not predict fluid responsiveness in spontaneously breathing patients after cardiac surgery.

Autor: Horejsek J; Department of Anaesthesiology and Intensive Care Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, 12808, Czech Republic., Balík M; Department of Anaesthesiology and Intensive Care Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, 12808, Czech Republic., Kunstýř J; Department of Anaesthesiology and Intensive Care Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, 12808, Czech Republic., Michálek P; Department of Anaesthesiology and Intensive Care Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, 12808, Czech Republic.; Department of Anaesthesia, Antrim Area Hospital, Antrim, BT41 2RL, UK., Kopecký P; Department of Anaesthesiology and Intensive Care Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, 12808, Czech Republic., Brožek T; Department of Anaesthesiology and Intensive Care Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, 12808, Czech Republic., Bartošová T; Department of Anaesthesiology and Intensive Care Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, 12808, Czech Republic., Fink A; First Faculty of Medicine, Charles University in Prague, Prague, 12808, Czechia., Waldauf P; Department of Anaesthesiology and Resuscitation, Third Faculty of Medicine, Charles University in Prague and University Hospital Královské Vinohrady in Prague, Prague, 10034, Czechia., Porizka M; Department of Anaesthesiology and Intensive Care Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, 12808, Czech Republic. michal.porizka@vfn.cz.

Publikováno v: Journal of clinical monitoring and computing [J Clin Monit Comput] 2023 Dec; Vol. 37 (6), pp. 1563-1571. Date of Electronic Publication: 2023 Aug 12.

Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11 , 6189.

Autor: Jansa P; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Ambrož D; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Aschermann M; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Černý V; Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Dytrych V; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Heller S; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Kunstýř J; Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Lindner J; 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Linhart A; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Nižnanský M; 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Pad'our M; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Prskavec T; 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Širanec M; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Edwards S; Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland., Gressin V; Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland., Kuhn M; Data Analysis Department, Institute of Biostatistics and Analysis Ltd., 602 00 Brno, Czech Republic., Di Scala L; Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland.

Publikováno v: Journal of clinical medicine [J Clin Med] 2023 Jun 09; Vol. 12 (12). Date of Electronic Publication: 2023 Jun 09.

Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension.

Autor: Jansa P; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Ambrož D; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Aschermann M; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Černý V; Department of Radiology, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Dytrych V; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Heller S; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Kunstýř J; Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Lindner J; 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Linhart A; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Nižnanský M; 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Paďour M; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Prskavec T; 2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Širanec M; 2nd Department of Internal Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic., Edwards S; Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland., Gressin V; Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland., Kuhn M; Data Analysis Department, Institute of Biostatistics and Analysis Ltd., 602 00 Brno, Czech Republic., Di Scala L; Actelion Pharmaceuticals Ltd., A Janssen Pharmaceutical Company of Johnson & Johnson, 4123 Allschwil, Switzerland.

Publikováno v: Journal of clinical medicine [J Clin Med] 2022 Oct 20; Vol. 11 (20). Date of Electronic Publication: 2022 Oct 20.